Australia: Health Alert (Australia) - 15 July 2013 - Part 2

This article is part of a series: Click Health Alert (Australia) - 15 July 2013 - Part 1 for the previous article.

Australia. Private Health Insurance Ombudsman

28 Jun 2013 - Removal of the rebate from Lifetime Health Cover (LHC) - from 1 July, the Rebate will not apply to LHC loading.... Read more

Australia. Private Health Insurance Administration Council

3 July 2013 - Capital Adequacy Standard – Interest Rate June 2013 - Private Health Insurance Administration Council (PHIAC) has determined that the interest rate applicable for the calculation of the renewal option amount to be applied by all private health insurers for the quarter ended 30 June 2013 is 2.471% per annum.

25 June 2013 - 2012–13 End of Year Reporting Requirements. 2012–13 End of Year Reporting Requirements

Australian Health Practitioner Regulation Agency (AHPRA)

9 July 2013 - AHPRA has published a request for quotation (RFQ) for developing a customised Governance training course. Submissions close 19 August 2013.| Read article

2 July 2013 - The Chinese Medicine Board of Australia releases its latest communique.| Read Article

4 July 2013 - The Medical Radiation Practice Board of Australia (MRPBA) has issued a position statement on using a protected title, such as "radiographer", under the National Law.| Read Article

5 July 2013 - The Ministerial Council has extended a transitional provision under section 284 of the National Law to 30 June 2015 for midwives in private practice providing intrapartum care for women who choose to homebirth.| Read Article

5 July 2013 - The Nursing and Midwifery Board of Australia releases its latest newsletter.| Read Article

3 July 2013 - The National Board has published important information on new applications for notation as an eligible midwife.| Read Article

1 July 2013 - The Occupational Therapy Board of Australia invites occupational therapists in South Australia to a free breakfast forum.| Read Article

5 July 2013 - The Osteopathy Board releases its latest communique.| Read Article

2 July 2013 - The Physiotherapy Board of Australia releases its latest communique. | Read Article

Australian Commission on Safety & Quality in Health Care

Medication Safety Update July 2013.

On the Radar – 8 July 2013 – Issue 134.

On the Radar – 1 July 2013 – Issue 133.

Advisory A13/04: Collection and reporting of Accreditation Evidence by Accrediting Agencies.

Accreditation evidence of implementation of the National Safety and Quality Health Service (NSQHS) Standards.

Data set specification for NSQHS Standards.

NSQHS Standards Guide for Small Hospitals Workbook.

National Inpatient Medication Chart Private Hospital Single Sheet (Day Surgery).

National Inpatient Medication Chart (Day Surgery).

National Inpatient Medication Chart (GP e-prescribing).

National Inpatient Medication Chart long-stay version (Paediatric Private Hospital version).

National Inpatient Medication Chart (Paediatric Private Hospital version).

National Inpatient Medication Chart long-stay version for acute care (Private Hospitals).

Australian Institute of Health & Welfare

3 July 2013 - Child and teenager oral health and dental visiting: results from the National Dental Telephone Interview Survey 2010. |Media release.

11 July 2013 - Disability support services: services provided under the National Disability Agreement 2011-12. |Media release

9 July 2013 - National Bowel Cancer Screening Program: July 2011 - June 2012 monitoring report. |Media release

5 July 2013 - Stroke and its management in Australia: an update. |Media release

5 July 2013 - Aboriginal and Torres Strait Islander Health Performance Framework 2012 report: Australian Capital Territory.

4 July 2013 - National housing and homelessness data dictionary: version 1, 2013.

Australia. National Health and Medical Research Council (NHMRC)

NHMRC Research Tracker - 28 June 2013.

NHMRC Licensing Committee 21st Biannual Report to Parliament.

Australia. Therapeutic Goods Administration

11 July 2013 - Australian Public Assessment Reports for prescription medicines (AusPARs). Added imatinib (as mesylate) (glivec), exenatide (byetta) and docetaxel (docetaxel-PF).

11 July 2013 - Documents released under Section 11C of the Freedom of Information Act 1982. Added Freedom of Information (FOI) 242-1213 and FOI 244-1213.

10 July 2013 - Orphan drugs. Added elosulfase-alpha.

10 July 2013 - Consultation: Options for reform of the regulatory framework for pharmacy compounding-This consultation closing date has been extended to 5pm, Friday 26 July 2013.

9 July 2013 - Advisory Committee on the Safety of Medicines (ACSOM). Added two new members.

9 July 2013 - GE Healthcare nuclear medicine imaging systems. GE Healthcare, in consultation with the Therapeutic Goods Administration (TGA), has initiated a recall for product correction for a number of its nuclear medicine imaging systems.

9 July 2013 - Cementless Columbus Knee System - used in knee replacements. Health professionals and consumers are advised that B. Braun Australia is withdrawing the cementless version of the Columbus Knee System from the Australian Register of Therapeutic Goods.

9 July 2013 - Hydroxyethyl starch (Voluven and Volulyte) and increased risk of mortality. The TGA has commenced a full risk benefit review of products containing hydroxyethyl starch.

9 July 2013 - Low value turnover application forms. Updated forms for 2013-14 financial year.

8 July 2013 - Complementary medicines: Cancellations from the ARTG following compliance review. Added four products cancelled from the Australian Register of Therapeutic Goods (ARTG) following compliance review for June 2013.

8 July 2013 - TGA Office of Complementary Medicines (OCM) road shows. A schedule informing stakeholders about the TGA's upcoming OCM roadshows in July and August.

8 July 2013 - Nite Rider capsules. The TGA has tested Nite Rider capsules and found that they contain an undeclared prescription substance.

8 July 2013 - Tocotrienols complex - palm: Proposed revision of draft compositional guideline, 2nd round consultation-Added submission received and TGA response.

8 July 2013 - Compositional guideline: Tocotrienols complex - palm. Added to current compositional guideline page.

5 July 2013 - A career as a Medical Officer at the TGA. The TGA employs about 35 medical officers, at various levels, in both full and part time positions. Additionally, we consistently seek applications from medical practitioners interested in working as medical officers at the TGA with non-ongoing opportunities.

5 July 2013 - Consultations on adoption of European Union guidelines in Australia. Added 8 guidelines proposed for adoption by TGA.

5 July 2013 - Early Warning System: health professional questions and answers. Questions and answers for health professionals about the Early Warning System.

5 July 2013 - Global crackdown against counterfeit and illegal medicines. Between 18 and 25 June 2013, the Australian Customs and Border Protection Service, the Therapeutic Goods Administration and the Australian Pesticides and Veterinary Medicines Authority took part in a week-long international crackdown on fake and illegal medicines purchased over the Internet.

5 July 2013 - Consultation: Regulation Impact Statement: Regulating the advertising of therapeutic goods to the general public. The closing date for this consultation has been extended to 19 July 2013.

4 July 2013 - Prescribing medicines in pregnancy database. Added fidaxomicin, pertuzumab, vismodegib, micafungin, retigabine, ruxolitinib phosphate.

Australia. National Mental Health Commission

11 July 2013 - Join the conversation.

1 July 2013 - Mentally healthy workplaces.

You might also be interested in...

Health Alert (Australia) - 15 July 2013 - Part 1
Health Alert (Australia) - 15 July 2013 - Part 3
Health Alert (Australia) - 15 July 2013 - Part 4
Health Alert (Australia) - 15 July 2013 - Part 5

© DLA Piper

This publication is intended as a general overview and discussion of the subjects dealt with. It is not intended to be, and should not used as, a substitute for taking legal advice in any specific situation. DLA Piper Australia will accept no responsibility for any actions taken or not taken on the basis of this publication.

DLA Piper Australia is part of DLA Piper, a global law firm, operating through various separate and distinct legal entities. For further information, please refer to

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

This article is part of a series: Click Health Alert (Australia) - 15 July 2013 - Part 1 for the previous article.
This article is part of a series: Click Health Alert (Australia) - 15 July 2013 - Part 3 for the next article.
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Mondaq Advice Centre (MACs)
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.